港股異動 | 微盟(2013.HK)漲超6%再創歷史新高 年內累漲超3倍
格隆匯9月2日丨微盟(2013.HK)高開高走,盤中高見13.92港元再創歷史新高,現報13.78港元,漲6.66%,暫成交6.6億港元,最新總市值310億港元,該股今年迄今已累漲超3倍。瑞信曾發研報指,微盟管理層透露預期本財年智能零售業務收入可按年增長1倍,平均年度合同值(ACV)達8-9萬元人民幣,並估計品牌商的ACV將可由22.7萬上升達到50萬元人民幣。該行將2021至2022年目標營銷收入預測提高4%及8%,並將每股盈利預測提高6%及10%,目標價升至14.3港元,評級維持“跑贏大市”。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.